Name: Global X Funds - Global X Commodity Strategy ETF (COMD) Fundamental & Financial Data
Creator: Stocktwits

SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is experiencing intense volatility following its first public quarterly report, as investors weigh a significant revenue beat and ambitious long-term growth projections against massive capital expenditures in AI infrastructure. The community is heavily focused on the looming expiration of the insider lock-up period, debating whether the upcoming share unlock will trigger a massive sell-off or if the market has already priced in the expected supply increase.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is seeing intense volatility and social media debate as investors weigh a strong earnings beat and record data center growth against concerns over high valuations, aggressive capital spending, and competitive pressure from Nvidia. While some traders are expressing frustration over a sharp after-hours sell-off, many community members remain optimistic, viewing the pullback as a buying opportunity and pointing to the company's long-term infrastructure roadmap.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is currently trending due to a legal battle with rival Eli Lilly over alleged misleading advertising for weight-loss drugs, combined with heavy community debate regarding pipeline execution and the competitive outlook of its GLP-1 treatments ahead of upcoming earnings. Investors are intensely focused on Wegovy pill prescription trends and long-term valuation concerns as the stock maintains a critical struggle around the psychological support level.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently trending as investors react to a significant restructuring of its digital distribution strategy in China, which aims to regain pricing control by cutting ties with thousands of third-party online sellers. While some view this as a necessary long-term turnaround move, community discourse remains polarized, with many retail investors expressing frustration over the stock's persistent underperformance and lack of momentum compared to broader market gains.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigen is seeing heightened investor attention as the community anticipates revenue updates and commercial milestones for Papzimeos, with significant discussion surrounding a substantial short interest and the potential for a short squeeze. Investors are actively debating the company's transition from a development-stage biotech to a commercial entity, highlighting enthusiasm for upcoming clinical data and future profitability.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors discuss a potential short squeeze and institutional accumulation, fueled by ongoing software sector rotation and speculation surrounding the company's long-term enterprise AI automation strategy. Community members are actively debating the stock's turnaround potential, highlighting strong fundamentals like high cash reserves and recurring revenue while bracing for high volatility ahead of upcoming earnings.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is rallying toward all-time highs as broad market momentum gains strength, fueled by intense investor focus on AI sector developments and anticipation surrounding corporate earnings. While bulls celebrate the sharp recovery, the community remains divided, with active debates centered on whether this rapid surge is a sustainable breakout or an overheated move susceptible to a sharp reversal.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is surging toward new all-time highs as traders capitalize on market momentum and speculative news surrounding a potential Iran-Hormuz peace deal. While bullish sentiment dominates, the community is actively debating whether this rally is an organic breakout or a liquidity trap, with many closely watching for confirmation of the deal and potential signals of market exhaustion.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending as investors react to the highly anticipated launch of its next set of BlueBird satellites, paired with recent collaborative workshops with Meta that suggest expanding commercial applications. The community is actively discussing the stock's potential to capture market share in the satellite-to-device broadband sector, focusing on the competitive positioning against other satellite providers and the strategic importance of its global mobile network operator partnerships.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust is seeing heightened activity as market participants closely monitor the metal's performance against broader inflation trends, geopolitical volatility, and the shifting strength of the U.S. dollar. Community discussions are heavily centered on whether current price levels represent an accumulation opportunity for a potential rebound or a continuation of a larger downward correction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Global X Funds - Global X Commodity Strategy ETF

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$26.99
Prev Close	$27.35
Open	$26.99
Dividend Yield	N/A
50-Day Moving Average	$27.09
Beta	N/A
Avg. Volume	656.05
PE Ratio	N/A

52-Week High	$29.64
52-Week Low	$24.24
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info